New statement released by anticoagulation forum

New statement released by anticoagulation forum
The Anticoagulation Forum has endorsed a new consensus statement aimed at optimizing the delivery of anticoagulation therapy to inpatients; the statement has been published in the May issue of the Annals of Pharmacotherapy.

(HealthDay)—The Anticoagulation Forum has endorsed a new consensus statement aimed at optimizing the delivery of anticoagulation therapy to inpatients; the statement has been published in the May issue of the Annals of Pharmacotherapy.

Edith A. Nutescu, Pharm.D., from the University of Illinois at Chicago, and colleagues from the Anticoagulation Forum reviewed the medical literature to identify published articles relating to the standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting.

The recommendations endorsed by the Anticoagulation Forum and included in the statement are aimed at informing the development of coordinated care systems containing elements with demonstrated benefit in improvement of outcomes. The paper addresses the areas of process, accountability, integration, standards of practice, provider education and competency, patient education, care transitions, and outcomes.

"This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients," the authors write.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

New blood-thinner measures may cut medication errors

May 22, 2013

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Recommended for you

FDA warning: men's testosterone drugs overused (Update)

14 hours ago

The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related ...

Early benefit assessment increases transparency for study data

18 hours ago

Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products (AMNOG). AMNOG was primarily aimed at containing the increasing drug expenditure of the statutory health insurance ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.